Received highly encouraging results on Barrambie project: Neometals Ltd (ASX: NMT) has received highly encouraging results from its initial Chinese metallurgical test work program on a 20kg diamond core sample of Barrambie project mineralistion which was taken from the high titanium grade eastern zone of the deposit. The clean mixed mineral concentrate was produced with combined Titanium, Vanadium and Iron levels of more than 92%. The metallurgical processing of mineral concentrate gave recoveries of more than 90% TiO2 and high recoveries for pig iron and vanadium product streams. Further, the results gave strong encouragement that a simple and conventional processing pathway can be developed to extract titanium, vanadium and iron products. The result also supports next stage of Pilot‐scale metallurgical test work. Moreover, an approximately 4 tonne representative bulk sample of the 40 tonne Barrambie DSO is currently on a ship to China, which will be put through extensive further testing. This test work is expected to be completed by year end. Along with this larger scale test work, NMT will continue to increase its marketing efforts in China to secure offtake partners for DSO. NMT has completed the mine planning activities for a DSO operation and is working with turn key mining solutions provider Adaman Resources to complete a comprehensive DSO operating cost model. The Barrambie project has a granted mining lease over the Resources and had previously got full environmental approval for a large primary vanadium mining and processing operation. Currently, NMT is completing updates to some of the previous environmental studies and expects to start seeking approvals for a DSO operation this quarter. Meanwhile, NMT stock has fallen 8.96% in three months as on July 10, 2018 but rose by about 3.3% on July 11, 2018.
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.